{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T07:32:26Z","timestamp":1763105546976},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In contrast to mild infections of Group A <jats:italic>Streptococcus<\/jats:italic> (GAS) invasive infections of GAS still pose a serious health hazard: GAS disseminates from sterile sites into the blood stream or deep tissues and causes sepsis or necrotizing fasciitis. In this case antibiotics do not provide an effective cure as the bacteria are capable to hide from them very quickly. Therefore, new remedies are urgently needed. Starting from a myxobacterial natural products screening campaign, we identified two fatty acids isolated from myxobacteria, linoleic and palmitoleic acid, specifically blocking <jats:italic>streptokinase-mediated<\/jats:italic> activation of plasminogen and thereby preventing streptococci from hijacking the host\u2019s plasminogen\/plasmin system. This activity is not inherited by other fatty acids such as oleic acid and is not attributable to the killing of streptococci. Moreover, both fatty acids are superior in their inhibitory properties compared to two clinically used drugs (tranexamic or \u03b5-amino caproic acid) as they show 500\u20131000 fold lower IC<jats:sub>50<\/jats:sub> values. Using a humanized plasminogen mouse model mimicking the clinical situation of a local GAS infection that becomes systemic, we demonstrate that these fatty acids ameliorate invasive GAS infection significantly. Consequently, linoleic and palmitoleic acid are possible new options to combat GAS invasive diseases.<\/jats:p>","DOI":"10.1038\/s41598-017-11276-z","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T11:22:54Z","timestamp":1505215374000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infection"],"prefix":"10.1038","volume":"7","author":[{"given":"Katharina","family":"Rox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten G.","family":"Loof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Gillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Bernecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gursharan Singh","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"11276_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.00101-13","volume":"27","author":"MJ Walker","year":"2014","unstructured":"Walker, M. J. et al. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin. Microbiol. Rev. \n                           27, 264\u2013301 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"11276_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. \n                           5, 685\u2013694 (2005).","journal-title":"Lancet Infect. Dis."},{"key":"11276_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-4419-8993-2_25","volume":"549","author":"JR Carapetis","year":"2004","unstructured":"Carapetis, J. R. Current issues in managing group A streptococcal infections. Adv. Exp. Med. Biol. \n                           549, 185\u2013190 (2004).","journal-title":"Adv. Exp. Med. Biol."},{"key":"11276_CR4","doi-asserted-by":"publisher","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","volume":"31","author":"JB Dale","year":"2013","unstructured":"Dale, J. B. et al. Group A streptococcal vaccines: Paving a path for accelerated development. Vaccine \n                           31, B216\u2013B222 (2013).","journal-title":"Vaccine"},{"key":"11276_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1128\/CVI.00795-14","volume":"22","author":"JB Dale","year":"2015","unstructured":"Dale, J. B. et al. Protective Immunogenicity of Group A Streptococcal M-Related Proteins. Clin. Vaccine Immunol. \n                           22, 344\u2013350 (2015).","journal-title":"Clin. Vaccine Immunol."},{"key":"11276_CR6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1126\/science.1101245","volume":"305","author":"H Sun","year":"2004","unstructured":"Sun, H. et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science \n                           305, 1283\u20131286 (2004).","journal-title":"Science"},{"key":"11276_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tim.2005.05.006","volume":"13","author":"MJ Walker","year":"2005","unstructured":"Walker, M. J., McArthur, J. D., McKay, F. & Ranson, M. Is plasminogen deployed as a Streptococcus pyogenes virulence factor? Trends Microbiol. \n                           13, 308\u2013313 (2005).","journal-title":"Trends Microbiol."},{"key":"11276_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1046\/j.1365-2958.2003.03797.x","volume":"51","author":"RK Aziz","year":"2004","unstructured":"Aziz, R. K. et al. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol. Microbiol \n                           51, 123\u2013134 (2004).","journal-title":"Mol. Microbiol"},{"key":"11276_CR9","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1182\/blood-2011-02-337568","volume":"118","author":"TG Loof","year":"2011","unstructured":"Loof, T. G. et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood \n                           118, 2589\u20132598 (2011).","journal-title":"Blood"},{"key":"11276_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. \n                           13, 34\u201345 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"11276_CR11","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.281.5383.1662","volume":"281","author":"X Wang","year":"1998","unstructured":"Wang, X. Crystal Structure of the Catalytic Domain of Human Plasmin Complexed with Streptokinase. Science \n                           281, 1662\u20131665 (1998).","journal-title":"Science"},{"key":"11276_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1128\/JB.186.1.110-121.2004","volume":"186","author":"A Kalia","year":"2004","unstructured":"Kalia, A. & Bessen, D. E. Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations. J. Bacteriol. \n                           186, 110\u2013121 (2004).","journal-title":"J. Bacteriol."},{"key":"11276_CR13","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1096\/fj.08-109348","volume":"22","author":"JD McArthur","year":"2008","unstructured":"McArthur, J. D. et al. Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation. FASEB J. \n                           22, 3146\u20133153 (2008).","journal-title":"FASEB J."},{"key":"11276_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/BJ20131305","volume":"458","author":"SM Cook","year":"2014","unstructured":"Cook, S. M., Skora, A. & Walker, M. J. Sanderson\u2011Smith, M. L. & McArthur, J. D. Site-restricted plasminogen activation mediated by group A streptococcal streptokinase variants. Biochem. J. \n                           458, 23\u201331 (2014).","journal-title":"Biochem. J."},{"key":"11276_CR15","doi-asserted-by":"publisher","first-page":"14579","DOI":"10.1074\/jbc.275.19.14579","volume":"275","author":"PD Boxrud","year":"2000","unstructured":"Boxrud, P. D., Fay, W. P. & Bock, P. E. Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen. J. Biol. Chem. \n                           275, 14579\u201314589 (2000).","journal-title":"J. Biol. Chem."},{"key":"11276_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/mmi.12037","volume":"86","author":"SM Cook","year":"2012","unstructured":"Cook, S. M., Skora, A., Gillen, C. M., Walker, M. J. & McArthur, J. D. Streptokinase variants from Streptococcus pyogenes isolates display altered plasminogen activation characteristics - implications for pathogenesis. Mol. Microbiol. \n                           86, 1052\u20131062 (2012).","journal-title":"Mol. Microbiol."},{"key":"11276_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1538-7836.2008.03220.x","volume":"7","author":"DC Rijken","year":"2009","unstructured":"Rijken, D. C. & Lijnen, H. R. New insights into the molecular mechanisms of the fibrinolytic system. J. Thromb. Haemost \n                           7, 4\u201313 (2009).","journal-title":"J. Thromb. Haemost"},{"key":"11276_CR18","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1073\/pnas.1201031109","volume":"109","author":"H Sun","year":"2012","unstructured":"Sun, H. et al. Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc. Natl. Acad. Sci \n                           109, 3469\u20133474 (2012).","journal-title":"Proc. Natl. Acad. Sci"},{"key":"11276_CR19","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.bmcl.2014.01.079","volume":"24","author":"BD Yestrepsky","year":"2014","unstructured":"Yestrepsky, B. D. et al. Development of tag-free photoprobes for studies aimed at identifying the target of novel Group A Streptococcus antivirulence agents. Bioorg. Med. Chem. Lett. \n                           24, 1538\u20131544 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"11276_CR20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1021\/np500144t","volume":"77","author":"R Jansen","year":"2014","unstructured":"Jansen, R., Mohr, K. I., Bernecker, S., Stadler, M. & M\u00fcller, R. Indothiazinone, an indolyl thiazolyl ketone from a novel myxobacterium belonging to the Sorangiineae. J. Nat. Prod. \n                           77, 1054\u20131060 (2014).","journal-title":"J. Nat. Prod."},{"key":"11276_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0021-9673(01)95986-2","volume":"541","author":"L Fay","year":"1991","unstructured":"Fay, L. & Richli, U. Location of double bonds in polyunsaturated fatty acids by gas chromatography-mass spectrometry after 4,4-dimethyloxazoline derivatization. J. Chromatogr. A \n                           541, 89\u201398 (1991).","journal-title":"J. Chromatogr. A"},{"key":"11276_CR22","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1016\/S0021-9258(17)30384-8","volume":"253","author":"BN Violand","year":"1978","unstructured":"Violand, B. N., Byrne, R. & Castellino, F. J. The effect of \u03b1-, \u03c9-amino acids on human plasminogen structure and activation. J Biol Chem \n                           253, 5395\u20135401 (1978).","journal-title":"J Biol Chem"},{"key":"11276_CR23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0021-9258(17)34189-3","volume":"254","author":"G Markus","year":"1979","unstructured":"Markus, G., Priore, R. L. & Wissler, F. C. The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J. Biol. Chem. \n                           254, 1211\u20131216 (1979).","journal-title":"J. Biol. Chem."},{"key":"11276_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0049-3848(86)90194-5","volume":"42","author":"A Takada","year":"1986","unstructured":"Takada, A., Makino, Y. & Takada, Y. Effects of tranexamic acid on fibrinolysis, fibrinogenolysis and amidolysis. Thromb. Res. \n                           42, 39\u201347 (1986).","journal-title":"Thromb. Res."},{"key":"11276_CR25","doi-asserted-by":"crossref","unstructured":"Loof, T. G., Deicke, C. & Medina, E. The role of coagulation\/fibrinolysis during Streptococcus pyogenes infection. Front. Cell. Infect. Microbiol. 4 (2014).","DOI":"10.3389\/fcimb.2014.00128"},{"key":"11276_CR26","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1182\/blood-2010-02-271858","volume":"116","author":"O Shannon","year":"2010","unstructured":"Shannon, O. et al. Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis. Blood \n                           116, 2365\u20132372 (2010).","journal-title":"Blood"},{"key":"11276_CR27","doi-asserted-by":"publisher","first-page":"14503","DOI":"10.1074\/jbc.273.23.14503","volume":"273","author":"V Pancholi","year":"1998","unstructured":"Pancholi, V. & Fischetti, V. A. \u03b1-Enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J. Biol. Chem. \n                           273, 14503\u201314515 (1998).","journal-title":"J. Biol. Chem."},{"key":"11276_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1078\/1438-4221-00283","volume":"293","author":"V Pancholi","year":"2003","unstructured":"Pancholi, V. & Chhatwal, G. S. Housekeeping enzymes as virulence factors for pathogens. Int. J. Med. Microbiol. IJMM \n                           293, 391\u2013401 (2003).","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"11276_CR29","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1128\/JB.01218-06","volume":"189","author":"ML Sanderson-Smith","year":"2007","unstructured":"Sanderson-Smith, M. L., Dowton, M., Ranson, M. & Walker, M. J. The Plasminogen-Binding Group A Streptococcal M Protein-Related Protein Prp Binds Plasminogen via Arginine and Histidine Residues. J. Bacteriol. \n                           189, 1435\u20131440 (2007).","journal-title":"J. Bacteriol."},{"key":"11276_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/272148","volume":"2012","author":"ML Sanderson-Smith","year":"2012","unstructured":"Sanderson-Smith, M. L., De Oliveira, D. M. P., Ranson, M. & McArthur, J. D. Bacterial plasminogen receptors: mediators of a multifaceted relationship. J. Biomed. Biotechnol. \n                           2012, 1\u201314 (2012).","journal-title":"J. Biomed. Biotechnol."},{"key":"11276_CR31","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1096\/fj.06-5804fje","volume":"20","author":"JN Cole","year":"2006","unstructured":"Cole, J. N. et al. Trigger for group A streptococcal M1T1 invasive disease. FASEB J. \n                           20, 1745\u20131747 (2006).","journal-title":"FASEB J."},{"key":"11276_CR32","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1096\/fj.07-105643","volume":"22","author":"ML Sanderson-Smith","year":"2008","unstructured":"Sanderson-Smith, M. L. et al. M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate. FASEB J. \n                           22, 2715\u20132722 (2008).","journal-title":"FASEB J."},{"key":"11276_CR33","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V96.7.2329","volume":"96","author":"H Tapper","year":"2000","unstructured":"Tapper, H. & Herwald, H. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood \n                           96, 2329\u20132337 (2000).","journal-title":"Blood"},{"key":"11276_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/138945012799424589","volume":"13","author":"JD McArthur","year":"2012","unstructured":"McArthur, J. D., Cook, S. M., Venturini, C. & Walker, M. J. The role of streptokinase as a virulence determinant of Streptococcus pyogenes - potential for therapeutic targeting. Curr. Drug Targets \n                           13, 297\u2013307 (2012).","journal-title":"Curr. Drug Targets"},{"key":"11276_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1538-7836.2011.04316.x","volume":"9","author":"H Sun","year":"2011","unstructured":"Sun, H. Exploration of the host haemostatic system by group A streptococcus: implications in searching for novel antimicrobial therapies: Exploration of the host haemostatic system by group A streptococcus. J. Thromb. Haemost. \n                           9, 189\u2013194 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"11276_CR36","doi-asserted-by":"publisher","first-page":"40891","DOI":"10.1074\/jbc.M112.404582","volume":"287","author":"A Hollands","year":"2012","unstructured":"Hollands, A. et al. A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. J. Biol. Chem. \n                           287, 40891\u201340897 (2012).","journal-title":"J. Biol. Chem."},{"key":"11276_CR37","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.bmc.2013.01.046","volume":"21","author":"BD Yestrepsky","year":"2013","unstructured":"Yestrepsky, B. D. et al. Novel inhibitors of bacterial virulence: Development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression. Bioorg. Med. Chem. \n                           21, 1880\u20131897 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"11276_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/cid\/ciu444","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens, D. L. et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin. Infect. Dis \n                           59, 147\u2013159 (2014).","journal-title":"Clin. Infect. Dis"},{"key":"11276_CR39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0310057X1504300604","volume":"43","author":"B Devaney","year":"2015","unstructured":"Devaney, B., Frawley, G., Frawley, L. & Pilcher, D. V. Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality. Anaesth. Intensive Care \n                           43, 685\u2013692 (2015).","journal-title":"Anaesth. Intensive Care"},{"key":"11276_CR40","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ijmm.2015.06.002","volume":"305","author":"A Fiebig","year":"2015","unstructured":"Fiebig, A. et al. Comparative genomics of Streptococcus pyogenes M1 isolates differing in virulence and propensity to cause systemic infection in mice. Int. J. Med. Microbiol. IJMM \n                           305, 532\u2013543 (2015).","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"11276_CR41","unstructured":"Gulotta, G. Elucidating the molecular mechanisms of streptococcal M protein-induced autoimmune sequelae (2015)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11276-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11276-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11276-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:00:10Z","timestamp":1671793210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-11276-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["11276"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-11276-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]},"assertion":[{"value":"17 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11798"}}